tiprankstipranks
First Tracks Biotherapeutics Inc (TRAX)
NASDAQ:TRAX
US Market
TRAX
First Tracks Biotherapeutics Inc
RESEARCH TOOLSreports
Want to see TRAX full AI Analyst Report?

First Tracks Biotherapeutics Inc (TRAX) Financial Statements

22 Followers

First Tracks Biotherapeutics Inc Financial Overview

First Tracks Biotherapeutics Inc's market cap is currently $607.83M. The company's EPS TTM is ; its P/E ratio is -6.20; First Tracks Biotherapeutics Inc is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ -139.61M$ -152.34M$ 0.00
Operating Income$ -179.01M$ -181.10M$ -118.46M
EBITDA$ -178.45M$ -178.70M$ -116.08M
Net Income$ -166.09M$ -163.71M$ -106.15M
Balance Sheet
Cash & Short-Term Investments$ 311.64M$ 385.37M$ 390.90M
Total Assets$ 330.55M$ 441.89M$ 444.11M
Total Debt$ 14.11M$ 16.04M$ 17.81M
Net Debt$ -224.08M$ -107.04M$ -18.15M
Total Liabilities$ 43.05M$ 50.30M$ 34.26M
Stockholders' Equity$ 287.49M$ 391.60M$ 409.85M
Cash Flow
Free Cash Flow$ -143.01M$ -126.16M$ -93.81M
Operating Cash Flow$ -142.93M$ -125.81M$ -93.00M
Investing Cash Flow$ 228.03M$ 95.40M$ 144.75M
Financing Cash Flow$ 30.01M$ 117.52M$ -87.09M
Currency in USD

First Tracks Biotherapeutics Inc Earnings and Revenue History

Income Statement >

First Tracks Biotherapeutics Inc Debt to Assets

Balance Sheet >

First Tracks Biotherapeutics Inc Cash Flow

Cash Flow >

First Tracks Biotherapeutics Inc Forecast EPS vs Actual EPS

Earnings >